NCT03134612

Brief Summary

This study aims to compare the effectivity between ondansetron 8 mg and lidocain 40 mg in preventing pain due to propofol injection

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
104

participants targeted

Target at P50-P75 for phase_2

Timeline
Completed

Started Jul 2016

Shorter than P25 for phase_2

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 1, 2016

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2016

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2016

Completed
8 months until next milestone

First Submitted

Initial submission to the registry

April 24, 2017

Completed
7 days until next milestone

First Posted

Study publicly available on registry

May 1, 2017

Completed
Last Updated

May 1, 2017

Status Verified

April 1, 2017

Enrollment Period

2 months

First QC Date

April 24, 2017

Last Update Submit

April 26, 2017

Conditions

Keywords

lidocainondansetronpainpropofol

Outcome Measures

Primary Outcomes (1)

  • The Degree of pain due to Propofol Injection

    The degree of pain due to propofol injection was measured at 0 second, 15 seconds, 30 second, using verbal rating scale

    Day 1

Study Arms (2)

Ondansetron

ACTIVE COMPARATOR

Ondansetron 8mg (2mg/cc) was given intravenously via a 20 G vein canula

Drug: Ondansetron 8 mg

Lidocain

ACTIVE COMPARATOR

Lidocain 40mg (20mg/cc + 2cc of normal saline) was given intravenously via a 20 G vein canula

Drug: Lidocain 40 mg

Interventions

Ondansetron
Lidocain

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Subjects aged 18-65 years old
  • Subjects were planned to undergo general anesthesia with propofol
  • Subjects with Body Mass Index (BMI) 18-35 kg/m2
  • Subjects with American Society of Anesthesiologists (ASA) physical status of I-II
  • Subjects with signed informed consent.

You may not qualify if:

  • Subjects with allergies to propofol, lidocain, ondansetron
  • Subjects with massive cardiac disorder
  • Subjects with cardiac rhythm disorder with or without treatment
  • Subjects with unstable hemodynamic
  • Subjects with contraindication to propofol, lidocain, ondansetron
  • Subjects with intubation and ventilation difficulty
  • Subjects with decreased consciousness, seizure history or head injury
  • Subjects with analgesic treatment history
  • Subjects with pregnancy.
  • Drop out criteria:
  • Subjects with allergic reactions induced by propofol, lidocain, ondansetron
  • Uncooperative subjects
  • Subjects in emergency
  • Subjects with difficult vein access in the dorsum manus
  • Subjects with infection and/or inflammation in the planned intravenous cannulation location.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Cipto Mangunkusumo Central National Hospital

Jakarta, DKI Jakarta, 10430, Indonesia

Location

Related Publications (35)

  • Marik PE. Propofol: therapeutic indications and side-effects. Curr Pharm Des. 2004;10(29):3639-49. doi: 10.2174/1381612043382846.

    PMID: 15579060BACKGROUND
  • Jalota L, Kalira V, George E, Shi YY, Hornuss C, Radke O, Pace NL, Apfel CC; Perioperative Clinical Research Core. Prevention of pain on injection of propofol: systematic review and meta-analysis. BMJ. 2011 Mar 15;342:d1110. doi: 10.1136/bmj.d1110.

    PMID: 21406529BACKGROUND
  • Tan CH, Onsiong MK. Pain on injection of propofol. Anaesthesia. 1998 May;53(5):468-76. doi: 10.1046/j.1365-2044.1998.00405.x.

    PMID: 9659020BACKGROUND
  • Johnson RA, Harper NJ, Chadwick S, Vohra A. Pain on injection of propofol. Methods of alleviation. Anaesthesia. 1990 Jun;45(6):439-42. doi: 10.1111/j.1365-2044.1990.tb14328.x.

    PMID: 2200299BACKGROUND
  • Macario A, Weinger M, Truong P, Lee M. Which clinical anesthesia outcomes are both common and important to avoid? The perspective of a panel of expert anesthesiologists. Anesth Analg. 1999 May;88(5):1085-91. doi: 10.1097/00000539-199905000-00023.

    PMID: 10320175BACKGROUND
  • Ye JH, Mui WC, Ren J, Hunt TE, Wu WH, Zbuzek VK. Ondansetron exhibits the properties of a local anesthetic. Anesth Analg. 1997 Nov;85(5):1116-21. doi: 10.1097/00000539-199711000-00029.

    PMID: 9356111BACKGROUND
  • Lee SK. Pain on injection with propofol. Korean J Anesthesiol. 2010 Nov;59(5):297-8. doi: 10.4097/kjae.2010.59.5.297. Epub 2010 Nov 25. No abstract available.

    PMID: 21179288BACKGROUND
  • Massad IM, Abu-Ali HM, Abu-Halaweh SA, Badran IZ. Venous occlusion with lidocaine for preventing propofol induced pain. A prospective double-blind randomized study. Saudi Med J. 2006 Jul;27(7):997-1000.

    PMID: 16830018BACKGROUND
  • Picard P, Tramer MR. Prevention of pain on injection with propofol: a quantitative systematic review. Anesth Analg. 2000 Apr;90(4):963-9. doi: 10.1097/00000539-200004000-00035.

    PMID: 10735808BACKGROUND
  • Mangar D, Holak EJ. Tourniquet at 50 mm Hg followed by intravenous lidocaine diminishes hand pain associated with propofol injection. Anesth Analg. 1992 Feb;74(2):250-2. doi: 10.1213/00000539-199202000-00014.

    PMID: 1731546BACKGROUND
  • Gan TJ, Diemunsch P, Habib AS, Kovac A, Kranke P, Meyer TA, Watcha M, Chung F, Angus S, Apfel CC, Bergese SD, Candiotti KA, Chan MT, Davis PJ, Hooper VD, Lagoo-Deenadayalan S, Myles P, Nezat G, Philip BK, Tramer MR; Society for Ambulatory Anesthesia. Consensus guidelines for the management of postoperative nausea and vomiting. Anesth Analg. 2014 Jan;118(1):85-113. doi: 10.1213/ANE.0000000000000002.

    PMID: 24356162BACKGROUND
  • Tramer MR, Reynolds DJ, Moore RA, McQuay HJ. Efficacy, dose-response, and safety of ondansetron in prevention of postoperative nausea and vomiting: a quantitative systematic review of randomized placebo-controlled trials. Anesthesiology. 1997 Dec;87(6):1277-89. doi: 10.1097/00000542-199712000-00004.

    PMID: 9416710BACKGROUND
  • Paventi S, Santevecchi A, Ranieri R. Efficacy of a single-dose ondansetron for preventing post-operative nausea and vomiting after laparoscopic cholecystectomy with sevoflurane and remifentanil infusion anaesthesia. Eur Rev Med Pharmacol Sci. 2001 Mar-Apr;5(2):59-63.

    PMID: 11863320BACKGROUND
  • Azimaraghi O, Aghajani Y, Molaghadimi M, Khosravi M, Eslami K, Ghadimi F, Movafegh A. Ondansetrona reduz a dor da injecao de etomidato: estudo randomico controlado. Braz J Anesthesiol. 2014 May-Jun;64(3):169-72. doi: 10.1016/j.bjan.2013.06.014. Epub 2014 Mar 7. No abstract available. Portuguese.

    PMID: 25456475BACKGROUND
  • Ambesh SP, Dubey PK, Sinha PK. Ondansetron pretreatment to alleviate pain on propofol injection: a randomized, controlled, double-blinded study. Anesth Analg. 1999 Jul;89(1):197-9. doi: 10.1097/00000539-199907000-00035.

    PMID: 10389803BACKGROUND
  • Zahedi H, Maleki A, Rostami G. Ondansetron pretreatment reduces pain on injection of propofol. Acta Med Iran. 2012;50(4):239-43.

    PMID: 22592573BACKGROUND
  • Powell RM, Buggy DJ. Ondansetron given before induction of anesthesia reduces shivering after general anesthesia. Anesth Analg. 2000 Jun;90(6):1423-7. doi: 10.1097/00000539-200006000-00032.

    PMID: 10825334BACKGROUND
  • Yeh HM, Chen LK, Lin CJ, Chan WH, Chen YP, Lin CS, Sun WZ, Wang MJ, Tsai SK. Prophylactic intravenous ondansetron reduces the incidence of intrathecal morphine-induced pruritus in patients undergoing cesarean delivery. Anesth Analg. 2000 Jul;91(1):172-5. doi: 10.1097/00000539-200007000-00032.

    PMID: 10866907BACKGROUND
  • Kyriakides K, Hussain SK, Hobbs GJ. Management of opioid-induced pruritus: a role for 5-HT3 antagonists? Br J Anaesth. 1999 Mar;82(3):439-41. doi: 10.1093/bja/82.3.439.

    PMID: 10434832BACKGROUND
  • Ye JH, Ponnudurai R, Schaefer R. Ondansetron: a selective 5-HT(3) receptor antagonist and its applications in CNS-related disorders. CNS Drug Rev. 2001 Summer;7(2):199-213. doi: 10.1111/j.1527-3458.2001.tb00195.x.

    PMID: 11474424BACKGROUND
  • Golparvar M, Saghaei M, Saadati MA, Farsaei S. Effect of ondansetron on prevention of post-induction hypotension in elderly patients undergoing general anesthesia: A randomized, double-blind placebo-controlled clinical trial. Saudi J Anaesth. 2015 Oct-Dec;9(4):365-9. doi: 10.4103/1658-354X.159455.

    PMID: 26543450BACKGROUND
  • Reddy MS, Chen FG, Ng HP. Effect of ondansetron pretreatment on pain after rocuronium and propofol injection: a randomised, double-blind controlled comparison with lidocaine. Anaesthesia. 2001 Sep;56(9):902-5. doi: 10.1046/j.1365-2044.2001.02059-6.x.

    PMID: 11531681BACKGROUND
  • Bolton CM, Myles PS, Carlin JB, Nolan T. Randomized, double-blind study comparing the efficacy of moderate-dose metoclopramide and ondansetron for the prophylactic control of postoperative vomiting in children after tonsillectomy. Br J Anaesth. 2007 Nov;99(5):699-703. doi: 10.1093/bja/aem236. Epub 2007 Aug 21.

    PMID: 17715139BACKGROUND
  • Deegan R. Ondansetron: pharmacology of a specific 5HT3-receptor antagonist. Am J Med Sci. 1992 Dec;304(6):373-8. doi: 10.1097/00000441-199212000-00009. No abstract available.

    PMID: 1456277BACKGROUND
  • Brill S, Middleton W, Brill G, Fisher A. Bier's block; 100 years old and still going strong! Acta Anaesthesiol Scand. 2004 Jan;48(1):117-22. doi: 10.1111/j.1399-6576.2004.00280.x.

    PMID: 14674982BACKGROUND
  • van Zundert A, Helmstadter A, Goerig M, Mortier E. Centennial of intravenous regional anesthesia. Bier's Block (1908-2008). Reg Anesth Pain Med. 2008 Sep-Oct;33(5):483-9. doi: 10.1016/j.rapm.2008.04.011.

    PMID: 18774520BACKGROUND
  • Rosenberg PH, Heavner JE. Multiple and complementary mechanisms produce analgesia during intravenous regional anesthesia. Anesthesiology. 1985 Jun;62(6):840-2. No abstract available.

    PMID: 4003822BACKGROUND
  • Shevchenko Y, Jocson JC, McRae VA, Stayer SA, Schwartz RE, Rehman M, Choudhry DK. The use of lidocaine for preventing the withdrawal associated with the injection of rocuronium in children and adolescents. Anesth Analg. 1999 Apr;88(4):746-8. doi: 10.1097/00000539-199904000-00011.

    PMID: 10195516BACKGROUND
  • Memis D, Turan A, Karamanlioglu B, Kaya G, Pamukcu Z. The prevention of propofol injection pain by tramadol or ondansetron. Eur J Anaesthesiol. 2002 Jan;19(1):47-51. doi: 10.1017/s0265021502000078.

    PMID: 11913803BACKGROUND
  • Mahler SA, Massey G, Meskill L, Wang H, Arnold TC. Can we make the basilic vein larger? maneuvers to facilitate ultrasound guided peripheral intravenous access: a prospective cross-sectional study. Int J Emerg Med. 2011 Aug 25;4:53. doi: 10.1186/1865-1380-4-53.

    PMID: 21867495BACKGROUND
  • Groothuis JT, van Vliet L, Kooijman M, Hopman MT. Venous cuff pressures from 30 mmHg to diastolic pressure are recommended to measure arterial inflow by plethysmography. J Appl Physiol (1985). 2003 Jul;95(1):342-7. doi: 10.1152/japplphysiol.00022.2003. Epub 2003 Apr 4.

    PMID: 12679358BACKGROUND
  • Flaherty SA. Pain measurement tools for clinical practice and research. AANA J. 1996 Apr;64(2):133-40.

    PMID: 9095685BACKGROUND
  • Williamson A, Hoggart B. Pain: a review of three commonly used pain rating scales. J Clin Nurs. 2005 Aug;14(7):798-804. doi: 10.1111/j.1365-2702.2005.01121.x.

    PMID: 16000093BACKGROUND
  • McCrirrick A, Hunter S. Pain on injection of propofol: the effect of injectate temperature. Anaesthesia. 1990 Jun;45(6):443-4. doi: 10.1111/j.1365-2044.1990.tb14329.x.

    PMID: 2200300BACKGROUND
  • Aubrun F, Paqueron X, Langeron O, Coriat P, Riou B. What pain scales do nurses use in the postanaesthesia care unit? Eur J Anaesthesiol. 2003 Sep;20(9):745-9. doi: 10.1017/s0265021503001212.

    PMID: 12974598BACKGROUND

MeSH Terms

Conditions

Pain

Interventions

Ondansetron

Condition Hierarchy (Ancestors)

Neurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

ImidazolesAzolesHeterocyclic Compounds, 1-RingHeterocyclic CompoundsCarbazolesIndolesHeterocyclic Compounds, 2-RingHeterocyclic Compounds, Fused-RingHeterocyclic Compounds, 3-Ring

Study Officials

  • Aries Perdana, Consultant

    Indonesia University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 2
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, CARE PROVIDER
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Consultant, Anesthesiologist

Study Record Dates

First Submitted

April 24, 2017

First Posted

May 1, 2017

Study Start

July 1, 2016

Primary Completion

September 1, 2016

Study Completion

September 1, 2016

Last Updated

May 1, 2017

Record last verified: 2017-04

Locations